[1] 周勇,谢彦军,田月洁,等.质子泵抑制剂及其不良反应[J],中国药物警戒,2007,4(5):303-306. [2] Saowanee Ngamruengphong, Grigorios I. Leontiadis, Saba Radhi,et al. Proton Pump Inhibitors and Risk of Fracture: A Systematic ReviewandMeta-AnalysisofObservational Studies[J].TheAmerican Journal of gastroenterology,2011;10(7):1209-1208. [3] Chun-Sick Eom, Sang Min Park, Seung-Kwon Myung, et al. Use of Acid-Suppressive Drugs and Risk of Fracture: A Meta-analysis ofObservationalStudies[J].Annalsoffamilymedicine,2011;9(3):256-267. [4] Xiaofei Yea,HongLiub,Cheng Wu,et al. Proton pump inhibitors therapy and risk of hip fracture:a systematic review and metaanalysis[J]. Wolters Kluwer Health,2011;23(9):794-800. [5] 王小蕾,王蔚虹,董欣红. 质子泵抑制剂对骨折风险影响的系统评价[J],中国循证医学,2012,12(2):216-223. [6] SheikhMS, Santa Ana C A, NicarMJ,et al.Gastrointestinal absorption of calciumfrommilk and calciumsalts[J].N Engl J Med,1987;317(9):532-536. [7] O'ConnellMB, Madden D M, Murray A M, et al. Effects of proton pump inhibitors on calcium carbonate absorption in women:arandomized crossover trial[J]. Am J Med,2005,118(7):778-781. [8] Pouwels S, Lalmohamed A, Souverein P, et al. Use of protonpump inhibitors and risk of hip/femur fracture: a population-basedcase-control study[J]. Osteoporos Int,2011,22(3):903-910. [9] Gagnemo-Persson R, Samuelsson A, Hakanson R, et al. Chickenparathyroid hormone gene expression in response to gastrin,ome-prazole, ergocalciferol, and restricted food intake[J]. CalcifTissue Int, 1997, 61(3): 210-215. [10] Chonan O, Takahashi R, Yasui H, et al. Effect of L-lactic acid on calcium absorption in rats fed omeprazole[J]. J Nutr Sci Vitaminol (Tokyo),1998,44:473-481. [11] Nabil SultanMD, Jose NazarenoMD, James GregorMD. Association between proton pump inhibitors and respiratory infections:A systematic review and meta-analysis of clinical trials [J].Can J Gastroenterol,2008,22(9):761-766. [12] J.Johnstone,K.Nerenber, M.Loeb.Meta-analysis: proton pump inhibitor use and the risk ofcommunity-acquired pneumonia [J].Blackwell Publishing Ltd,2010,31, 1165-1177. [13] Christopher Giuliano, Sheila M Wilhelm,Kale-Pradhan, et al. Are proton pump inhibitors associated with the development of community-acquired pneumonia A meta-analysis [J]. Expert Rev.Clin. Pharmacol,2012,5(3),:337-344. [14] G.Trikudanathan,J. Israel,J. Cappa, et al.Association between proton pump inhibitors and spontaneous bacterial peritonitis in cirrhoticpatients-asystematicreviewandmeta-analysis[J].Blackwell Publishing Ltd Int J Clin Pract,2011,65(6):674-678. [15] 羊钦裕,白海涛.质子泵抑制剂诱发感染危险性研究进展[J]. 中国实用儿科杂志,2011, 26(9):709-711. [16] Abhishek Deshpande, Chaitanya Pant,Vinay Pasupulet, et al. Association Between Proton Pump Inhibitor Therapy and Clostridium dif?cile Infection in a Meta-Analysis[J]. Clinical Gastroenterology And Hepatology,2012,10(3):225-233. [17] Chun Shing Kwok, Mbbs Msc,A aron Kobina, et al. Risk of Clostridium dif cile Infection With Acid Suppressing Drugs and Antibiotics: Meta-Analysis[J].The American College of Gastroenterology, 2012,107:1011-1019. [18] Sailajah lajah janarthanan, lvo Ditah,MPhil, et al. Clostridium dif cile-Associated Diarrhea and Proton Pump Inhibitor Therapy: A Meta-Analysis[J]. The American Journal of Gastroenerology,2012, 107:1001-1011. [19] 黄瑾,刘正跃,田泾.长期大剂量使用质子泵抑制剂的严重不良反应和药学监护[J],中国医院药学杂志,32(20):1648-1651. [20] Gau J T, Yang Y X, Chen R, et al.Uses of proton pump inhibitors and hypomagnesemia[J]. Pharmacoepidemiol Drug Saf,2012, 21(5):553-559. [21] 国家食品药品监督管理局.警惕质子泵抑制剂引起骨折、低镁血症的风险以及与氯吡格雷的相互作用,药品不良反应信息通报第55 期. |